Supplemental Table Legend from A Cell-Based MAPK Reporter Assay Reveals Synergistic MAPK Pathway Activity Suppression by MAPK Inhibitor Combination in BRAF-Driven Pediatric Low-Grade Glioma Cells

MLA

Till Milde, et al. Supplemental Table Legend from A Cell-Based MAPK Reporter Assay Reveals Synergistic MAPK Pathway Activity Suppression by MAPK Inhibitor Combination in BRAF-Driven Pediatric Low-Grade Glioma Cells. Apr. 2023. EBSCOhost, https://doi.org/10.1158/1535-7163.22521343.v1.

APA

Till Milde, Olaf Witt, Tilman Brummer, Marc Remke, David T.W. Jones, Stefan M. Pfister, Cornelis M. van Tilburg, Darren Hargrave, Tobias Rubner, Alexander C. Sommerkamp, Johanna Vollmer, Thomas Hielscher, Jonas Ecker, Stefan Pusch, Jennifer Jansen, David Pauck, Viktoria Marquardt, Florian Selt, Juliane L. Buhl, … Diren Usta. (2023). Supplemental Table Legend from A Cell-Based MAPK Reporter Assay Reveals Synergistic MAPK Pathway Activity Suppression by MAPK Inhibitor Combination in BRAF-Driven Pediatric Low-Grade Glioma Cells. https://doi.org/10.1158/1535-7163.22521343.v1

Chicago

Till Milde, Olaf Witt, Tilman Brummer, Marc Remke, David T.W. Jones, Stefan M. Pfister, Cornelis M. van Tilburg, et al. 2023. “Supplemental Table Legend from A Cell-Based MAPK Reporter Assay Reveals Synergistic MAPK Pathway Activity Suppression by MAPK Inhibitor Combination in BRAF-Driven Pediatric Low-Grade Glioma Cells,” April. doi:10.1158/1535-7163.22521343.v1.